These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 860117)
21. Letter: Fibrinolytic activity and treatment of diabetes. Farid NR Lancet; 1974 Jul; 2(7874):220. PubMed ID: 4135639 [No Abstract] [Full Text] [Related]
22. Current therapy of diabetes and its rationale. Turtle JR Aust N Z J Med; 1971 Aug; 1():Suppl 2:13-21. PubMed ID: 5292786 [No Abstract] [Full Text] [Related]
24. [Therapeutical principles and drug therapy of diabetes in adults]. Constam GR Med Welt; 1975 Oct; 26(40):1837-42. PubMed ID: 1186478 [No Abstract] [Full Text] [Related]
25. [Indications and contraindications of biguanide therapy in diabetes mellitus]. Tatón J Z Gesamte Inn Med; 1981 Jan; 36(2):33-7. PubMed ID: 7222845 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of diabetes without biguanides. Observation on the course after changing treatment (author's transl)]. Walter-Sack I; Wolfram G; Zöllner N MMW Munch Med Wochenschr; 1979 Aug; 121(35):1109-12. PubMed ID: 114774 [TBL] [Abstract][Full Text] [Related]
27. UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year. Diabetologia; 1983 Jun; 24(6):404-11. PubMed ID: 6350078 [No Abstract] [Full Text] [Related]
28. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus]. Ninni M; Castelletta L Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364 [No Abstract] [Full Text] [Related]
29. [Second generation sulfonylurea preparations in the therapy of diabetes mellitus]. Kliachko VR; Perelygina AA; Mazovetskiĭ AG Probl Endokrinol (Mosk); 1975; 21(5):3-6. PubMed ID: 132655 [TBL] [Abstract][Full Text] [Related]
30. [Oral hypoglycemic agents]. Pupo Ade A AMB Rev Assoc Med Bras; 1986; 32(11-12):202-4. PubMed ID: 3299518 [No Abstract] [Full Text] [Related]
31. Glibenclamide (HB 419, Daonil) in the clinical practice of diabetes. Krall LP; Sinha S; Goldstein HH Aust N Z J Med; 1971 Aug; 1():Suppl 2:57-62. PubMed ID: 5005132 [No Abstract] [Full Text] [Related]
33. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]
34. [Radioimmunological determination of insulin in patients with manifest diabetes mellitus as a guide for the planning of therapy (author's transl)]. Zilker T; Kränzlin T; Schweigart U; Ermler R; Bottermann P Med Klin; 1976 Apr; 71(18):761-7. PubMed ID: 818495 [TBL] [Abstract][Full Text] [Related]
36. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide]. Vogel G; Krummel E Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514 [No Abstract] [Full Text] [Related]
37. Effect of discontinuation of biguanide therapy on metabolic control in maturity-onset diabetics. Siitonen O; Aro A; Huttunen JK; Juvonen H; Järvinen R; Korhonen T; Palomäki P; Ritala P Lancet; 1980 Feb; 1(8162):217-20. PubMed ID: 6101675 [TBL] [Abstract][Full Text] [Related]
38. [Oral anti-diabetes medicines, an update]. Melero Paredes S; Antolínez de Abia N Rev Enferm; 2008 Mar; 31(3):7-10. PubMed ID: 18444365 [TBL] [Abstract][Full Text] [Related]